• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Medical Affairs Asia 2012
 

Medical Affairs Asia 2012

on

  • 285 views

International and regional experts coming together ...

International and regional experts coming together
to discuss strategies and opportunities in the Medical
Affairs function
• Unique insights and case studies on experiences in
the Asia market, successful programmes and best
practices
• Detailed and practical workshop to complement
your learning and networking experience

Statistics

Views

Total Views
285
Views on SlideShare
282
Embed Views
3

Actions

Likes
0
Downloads
3
Comments
0

1 Embed 3

http://www.slideee.com 3

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Medical Affairs Asia 2012 Medical Affairs Asia 2012 Document Transcript

    • Dr Richard Nieman Vice President, Head of Global Medical Affairs, Asia, Bayer Healthcare Pharmaceuticals, China Dr Elena Rizova Vice President Medical Affairs, JanssenPharmaceutical, Singapore 5 – 7 December 2012 • Grand Copthorne Waterfront Hotel, Singapore MEDICAL AFFAIRSMEDICAL AFFAIRS FORUM AS A 2012FORUM AS A 2012 Bridging Science and Commerce in Asia’s Pharma Markets Produced by: www.medicalaffairs-asia.com REGISTER NOW! Customer Service Hotline: +65 6508 2401 Media Partners: International Marketing Partner: Featuring Keynote Speakers: Plus insights from: Dr Abhishek Bhagat, Regional Associate Medical Director, Mundipharma, Singapore Dr Vicknesh Welluppillai, Medical Director, Pfizer, Malaysia Dr Helen Lin, MedicalAffairsDirector,R&D, AstraZeneca, China Dr AjayTiku, RegionalMedicalDirector,CardiovascularDisease – Asia Pacific, Bristol Myers Squibb, Singapore Dr Benjamin G. Co, Medical Director, Otsuka, Philippines Dr Jude Selvaraj, MedicalLead:Malaysia/Singapore/Indonesia/ Brunei, Eli Lilly, Malaysia Dr Ping Liu, Director of Medical Affairs, UCB, China Bridging Science and Commerce in Asia’s Pharma Markets Attend Asia’s 1st Medical Affairs Conference to: • Acquire the necessary knowledge required to tackle the Medical Affairs’ growing strategic role • Hear from Medical Directors how the Medical Affairs function is continuously re-invented by optimizing capabilities • Network with industry thought leaders and your peers from global pharma operating in the region • Gather practical advice on how to improve communication and relationships with KOLs • Listentoexperts as they discuss how to achieve and keep an experienced and competent Medical Affairs team Key themes and issues to be discussed include: • Pharma Industry Updates: Trends and Realities in the Region and Globally • Dissecting the Medical Affairs Function: Roles, Responsibilities and Reach • AccuratelyCommunicating Scientific Information for Internal and External Partners • Case Studies: Focus on Opportunities, Challenges, Issues and Strategies for Success • Strengthening KOL Engagement and Collaboration Cultivating a Medical Affairs Mindset: The Essence and a Few Essentials PLUS! Post-Conference Workshop: 7 December 2012 Dr Seong-Choon Choe, Senior Vice President, HanAll Biopharma, Korea Dr Karen Smith Senior Vice President and Head, Global Medical Affairs, Allergan, USA
    • REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.medicalaffairs-asia.com MEDICAL AFFAIRSMEDICAL AFFAIRS FORUM AS A 2012FORUM AS A 2012 Bridging Science and Commerce in Asia’s Pharma Markets Bridging Science and Commerce in Asia’s Pharma Markets CONFERENCE DAY ONE Wednesday | 5 December 2012 8:30 Registration and Morning Coffee 9:00 Chairperson’s Opening Remarks Dr Seong-Choon Choe, Senior Vice President, HanAll Biopharma, Korea Pharma Industry Updates: Trends and Realities in the Region and Globally 9:10 Scanning the Pharmaceutical Industry’s Evolving Framework • Today’s healthcare environment: trends, challenges and opportunities • What are the drivers of change and productivity? • Responding to change in the industry through the Medical Affairs function Dr Karen Smith, Senior Vice President and Head, Global Medical Affairs, Allergan, USA 9:50 Asia’s Medical Affairs Landscape: What Makes the East Different? • State of pharma/biotech business in Asia • The important role of investigator-initiated studies vis-à- vis CME oriented programmes • Cultural and language differences and what they mean for the global pharma professional Dr Richard Nieman, Vice President, Head of Global Medical Affairs, Asia, Bayer Healthcare Pharmaceuticals, China 10:30 Morning Refreshments 11:00 CME Advocacy in Asia Pacific Region • Challenges in organizing continuing education and awareness to doctors and KOLs • How to effectively involve government, public and doctors Dr Elena Rizova, Vice President Medical Affairs, Janssen Pharmaceutical, Singapore 11:40 Setting a Regional Benchmark for the Medical Affairs Profession • Do Asia markets and KOLs respond differently? • Trends in regulatory administration to keep abreast of • Gaining buy in from both internal and external stakeholders Moderator: Dr Karen Smith, Senior Vice President and Head, Global Medical Affairs, Allergan, USA Panelists: Dr Richard Nieman, Vice President, Head of Global Medical Affairs, Asia, Bayer Healthcare Pharmaceuticals, China Dr Elena Rizova, Vice President Medical Affairs, Janssen Pharmaceutical, Singapore 12:30 Networking Lunch 1:30 Impact of ASEAN Harmonization and Global Trends • Update on the ASEAN harmonization with focus on medical devices • Review of regulations and government updates in key countries in Asia • Outlook for the Asian regulatory scene Jack Wong, Regulatory Affairs Director, Johnson & Johnson, Singapore Dissecting the Medical Affairs Function: Roles, Responsibilities and Reach 2:10 Measuring the Medical Affairs Function: What Are Our KPIs? • What are the roles, expectations and responsibilities of an MSL in a pharmaceutical company? • What traditional roles of sales have medical affairs taken over? • Forging ahead as an ambassador across the scientific and public health community • Structuring and coordinating medical affairs activities – key factors for success Dr Ajay Tiku, Regional Medical Director, Cardiovascular Disease – Asia Pacific, Bristol Myers Squibb, Singapore 2:50 Critical Role of Medical Affairs in Clinical Development • Understanding the relationship in a company between clinical R&D and medical affairs • Updates on recent clinical development that affects the MA function • How important is data management? • Establishing partnerships in clinical development through the MA channel Dr Jyoti Bedi, Medical Adviser – Strategic Medical Affairs, New Initiative, Panacea Biotec, India 3:30 Afternoon Refreshments 4:00 What is the Potential for Contract Medical Organisations (CMOs) in Asia? • Increase in medical and scientific credibility • Providing efficient and effective leadership • Ensuring patient safety and outcomes Thissessionpresentsanopportunityforsolutionproviders to showcase their expertise and how it can support and improve the medical affairs function For inquiries, contact Yvonne Leong at yvonne.leong@ibcasia.com.sg / +65-6508 2489 4:40 Keeping up with Complex Scientific and Medical Information • Transforming scientific data to useful, relevant information for all • The need for better quality of information • Access to epidemiological data • Skills needed to communicate complex, scientific data into useful information to doctors and patients Dr Seong-Choon Choe, Senior Vice President, HanAll Biopharma, Korea 5:20 End of Conference Day One PANELDISCUSSION
    • REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.medicalaffairs-asia.com MEDICAL AFFAIRSMEDICAL AFFAIRS FORUM AS A 2012FORUM AS A 2012 Bridging Science and Commerce in Asia’s Pharma Markets Bridging Science and Commerce in Asia’s Pharma Markets CONFERENCE DAY TWO Thursday | 6 December 2012 Accurately Communicating Scientific Information for Internal and External Partners 2:10 Ensuring Smooth Communication and Work Relationships with KOLs • Importance of networking and how to do it right • Establishing criteria to evaluate needs and goals for KOL engagement • Value exchange to improve relationships, build credibility and motivate your KOLs Dr Vicknesh Welluppillai, Medical Director, Pfizer, Malaysia 2:50 Afternoon Refreshments 3:20 Combating the Shortage of Trained MA/MSLs to Meet Asia’s Needs • What is the extent of the problem and how is it being addressed in Asia? • Models that have been successful in mature markets • Prioritising resources to mitigate the shortage of efficient MA professionals Dr Jude Selvaraj, Medical Lead: Malaysia/Singapore/ Indonesia/Brunei, Eli Lilly, Malaysia 4:00 Developing Appropriate Positioning for New Products to Leverage New Indications • Franchise analysis and how to position new product while keeping existing ones on the same market • Can new indications help to maintain the price premium in China? • New indications and post-marketing studies: data gap analysis Dr Ping Liu, Director of Medical Affairs, UCB, China 4:40 Drug Reimbursement, Government Involvement and the Medical Affairs Function • Responding to dynamic industry trends • Prioritizing resources to make medical affairs more efficient • Lessons learned from working in a global community • Predicting the changing role of MA in the next 5 years Moderator: Dr Aamir Shaikh, Founder, Assansa, India Panelists: Dr Benjamin G. Co, Medical Director, Otsuka, Philippines Dr Vicknesh Welluppillai, Medical Director, Pfizer, Malaysia Dr Jude Selvaraj, Medical Lead: Malaysia/Singapore/ Indonesia/Brunei, Eli Lilly, Malaysia Dr Ping Liu, Director of Medical Affairs, UCB, China 5:30 Chairperson’s Summary & End of Conference PANELDISCUSSION “Knowledge sharing, variety of topics on different countries. Networking, cosmopolitan, diversity of people. Good dynamic presentation, panel, enable interactions” ~ Johnson & Johnson 9:00 Chairperson’s Welcome Remarks and Recap of Day One DrBenjaminG.Co, MedicalDirector, Otsuka, Philippines Case Studies: Focus on Opportunities, Challenges, Issues and Strategies for Success 9:10 The Use of Digital Technology to Promote Science and Marketing • Making digital technology work for your company work force • Patient health access through technology • eDetailing in changing scenarios of the pharmaceutical industry DrBenjaminG.Co, MedicalDirector, Otsuka, Philippines 9:50 Evolution of Field Based Medical Functions in Korea • Recent Evolution of Ethical Business Practice • Current status of Field based Medical functions in Korea • Leadership of KSPM to evolve FBM Dr Won-Sik Lee, Medical Director & PC BU Medcial Lead, Pfizer, Korea 10:30 Morning Refreshments Strengthening KOL Engagement and Collaboration 11:00 Medical Affairs for Orphan Drugs / Novel Drugs/ Medical Device Forspeakerupdate,pleasevisit www.medicalaffairs-asia.com 11:40 Balancing Science and Sales: Adhering to Research while Aligning with Commercial Goals • Adherence of marketing to compliance • Communicating evidence-based value to stakeholders • Differentiating the MSL and Sales Reps Dr Helen Lin, MedicalAffairsDirector,R&D, AstraZeneca, China 12:20 Networking Lunch 1:30 Creating Synergy among Sales, Marketing and the Medical Affairs Teams • Developing appropriate positioning for new products and help to leverage new indications • Knowing when collaboration is not possible (ethical or compliance reasons) • Effective communication to internal stakeholders Dr Abhishek Bhagat, Regional Associate Medical Director, Mundipharma, Singapore
    • REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.medicalaffairs-asia.com “Comprehensive overview of regulatory requirements of major regions around the world” ~ Bayer “Excellent topics and speakers” ~ Novartis “Very informative” ~ National Pharmaceutical Control Bureau, Malaysia MEDICAL AFFAIRSMEDICAL AFFAIRS FORUM AS A 2012FORUM AS A 2012 Bridging Science and Commerce in Asia’s Pharma Markets Bridging Science and Commerce in Asia’s Pharma Markets WORKSHOP Post-Conference Workshop | FRIDAY | 7 December 2012 | 9.00am – 12.30pm This workshop will run from 9:00-12:30 with mid-morning refreshments. Registration begins 30 minutes before the session commences. Past participating organizations at IBC’s past related events include: ACTELION PHARMACEUTICALS • ALLERGAN • AMGEN • ASTRAZENECA • BAYER HEALTH CARE • BECTON DICKINSON • BEIGENE • BOEHRINGER INGELHEIM • BRISTOL MYERS SQUIBB • CELLTRION • CHUGAI PHARMACEUTICAL • DAEWOONG PHARMACEUTICAL • DAIICHI SANKYO • DEXA MEDICA • ELI LILLY & COMPANY • GENZYME CHINA • GSK • GSK BIOLOGICALS • HANDOK PHARMACEUTICALS • HENLIUS BIOPHARMACEUTICALS • HOFFMANN LA ROCH • HUMAN GENOME SCIENCES • IPSEN • JIANGSU HENGRUI MEDICINE CO • JOHNSON & JOHNSON MEDICAL • KADMON • KALBE FARMA • LG LIFE SCIENCES • LUNDBECK • MERCK SHARP & DOHME • NOVARTIS • NOVO NORDISK • PFIZER • PHARMANIAGA • SANBE FARMA • SANKYO • SANOFI PASTEUR • SANOFI-AVENTIS • SFDA • TAIHO PHARMACEUTICAL • TAKEDA PHARMACEUTICAL• AND MORE... SPEAK, SPONSOR AND NETWORK AT MEDICAL AFFAIRS FORUM ASIA This event offers you a unique opportunity to showcase your expertise in front of key decision-makers. Maximize your marketing dollars by exhibiting or presenting your expertise at this event. Increase your exposure further by sponsoring a breakfast, luncheon or cocktail reception! To learn more about these opportunities, please contact: Yvonne.leong@ibcasia.com.sg / +65 6508 2489 Workshop Objectives: • Describe the core responsibility and competency requirements of a medical affairs professional • Discuss and highlight the need and importance of cultivating a medical affairs mindset • Identify and describe the key requirements / characteristics / qualities of this medical affairs mindset • Understand an approach towards self-development; craft an effective personal development plan towards cultivating this mindset Who Should Attend: This workshop will be useful to both new and experienced Medical Affairs Professionals Brief Outline: • The core responsibility and competency requirements of a medical affairs professional are somewhat unique and extremely challenging • While developing the core technical/functional/medical competencies is a must, understanding the need for and cultivating a medical affairs mindset is at the very essence of achieving success • This mindset is often difficult to cultivate because apart from medical capabilities, it involves/requires a need for a few essentials – these include accountability, balance, clarity, sound judgment and decision making, a development focus and ethical thought, behaviour and action Cultivating a Medical Affairs Mindset: The Essence and a Few Essentials Aamir Shaikh, Founder, Assansa Aamir was previously Director of Medical Affairs & Research for Pfizer India. In this capacity, he nurtured, led and grew teams of Medical Affairs Professionals across varied functional and therapeutic areas. In 2007, Aamir founded Assansa – a consultancy which specializes in designing and delivering Professional Development Programs and Customized Learning Experiences for the health care industry and academia in the following core health care and pharmaceutical industry domains: Pharmaceutical Medicine; Medical / Clinical Research, Education & Practice; and Health Care Leadership Development. “High level of discussion with exchanges that spans from a multi faceted area. Very impressed and learnt a lot” ~ KK Women’s & Children’s Hospital “Havingtherighttopicsinterestedmeandtheenvironmentbeing friendly and conducive to networking” ~ Proctor & Gamble Led by:
    • 5 – 7 December 2012 • Grand Copthorne Waterfront Hotel, Singapore MEDICAL AFFAIRSMEDICAL AFFAIRS FORUM AS A 2012FORUM AS A 2012 Bridging Science and Commerce in Asia’s Pharma Markets Bridging Science and Commerce in Asia’s Pharma Markets REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.medicalaffairs-asia.com Across the board, the pharma industry is under increasing attack from all sides... • 2007 – Purdue Pharma settled for $634 million for illegally promoting OxyContin as less addictive than other painkillers • 2009 – Eli Lilly settled for $1.4 billion for illegally marketing Zyprexa for the treatment of dementia, despite being approved only for the use of schizophrenia and bipolar disorder • 2009–Pfizersettledfor$2.3billionforillegallypromotingBextra • 2011 – Merck agreed to pay $950 million to settle complaints that it had illegally marketed Vioxx • 2012 – Abbott settled for $1.6 billion for illegally marketing an anti-seizure drug • 2012–GSKfined$3billionformarketingdrugsforunauthorized uses • Any day now, the Justice Department is expected to announce that Johnson & Johnson has settled claims that it illegally promoted Risperdal with expected settlement of about $2.2 billion Could these situations have been prevented and millions saved with an empowered Medical Affairs team? The modern-day pharmaceutical Medical Affairs function has transformed into an incredibly challenging and complex role. This entails a gamut of activity, from bridging research, clinical development, scientific publications, health outcomes, medical education and KOL relationship among others.This timely forum will bring together medical affairs professionals to address common issues to improve the way pharma business is done in Asia. IBC’s MEDICAL AFFAIRS FORUM ASIA is the 1ST and ONLY high level platform for you and your peers to come together, share best practices and leverage on-the-job learning. Comprising a 2 day conference and post event workshop, it has been researched with your needs in mind. Its aim is to enable you to be even more effective in enhancing the company’s scientific reputation while communicating the value and proper use of a product. Pharma companies have been heavily penalised in the past amid ever-stricter regulations. The time is ripe for Medical Affairs professionals to come together and talk about things that matter. Hear from other experts on how they’ve overcome the challenges you could also be facing. Don’t miss this informative and thought- provoking meeting. BookYour Seat Now at www.medicalaffairs- asia.com or Call +65 6508 2401 today! Why Prevention is Better than Cure... Who Should Attend: Involved in the following: • Medical / Scientific Affairs • Medical & Clinical Affairs • Medical / Scientific Communications / Information • Medical Education & Publications • Government Affairs • Legal • Marketing • Compliance • Regulatory Affairs • Pharmacovigilance • International and regional experts coming together to discuss strategies and opportunities in the Medical Affairs function • Unique insights and case studies on experiences in the Asia market, successful programmes and best practices • Detailed and practical workshop to complement your learning and networking experience Conference Highlights: Others 7% Attendees by Country Singapore 30% Indonesia 10% Korea 5% Thailand 5% China 5% Philippines 5% USA / Rest of the World 5% Vietnam 5% India 5% Malaysia 20% Others 5% • Medical Directors • Medical Managers • Medical Advisors • Medical Science Liaison • Medical Writers • Chief Medical Officers From: • Pharmaceutical Companies • CROs • Medical Device & Diagnostics • Contract Medical Organizations (CMOs) • Medical Writing Companies • Staffing and Outsourcing Companies Attendees by Industry Pharma 75% CROs 10% Medical Device 8%
    • ENJOY SUBSTANTIAL SAVINGS WITH OUR MULTIPLE BOOKING DISCOUNT! MAIL the attached registration form with your cheque to IBC Asia (S) Pte Ltd c/o Informa Regional Business Services 111 Somerset Road, TripleOne Somerset #10-06, Singapore 238164 Early Bird Rate Register & pay before 21 Sep 2012 FEE PER DELEGATE Special Rate Register & pay before 26 Oct 2012 Group Rate (3 or more delegates) Normal Rate Register & pay after 26 Oct 2012 REGISTER NOW! FAX BACK TO +65 6508 2407 HOTEL INFORMATION DATA PROTECTION PAYMENT TERMS CANCELLATIONS / SUBSTITUTION IMPORTANT NOTE This label contains your priority booking code. To expedite registration, please do not remove label. If you have already received a copy of this brochure, we apologise. For reasons of confidentiality, your full particulars were not available to IBC Asia (S) Pte Ltd for deduplication prior to mail drop. 5 EASY WAYS TO REGISTER Email register@ibcasia.com.sg Customer Service Hotline +65 6508 2401 Fax +65 6508 2407 Web www.medicalaffairs-asia.com ❑ Yes! I/We will attend the Medical Affairs Forum Asia 2012 | 5 – 7 December 2012, Grand Copthorne Waterfront Hotel, Singapore REGNO.200108203N The personal information entered during your registration/ order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Sometimes your details may be obtained from or shared with external companies for marketing purposes. If you do not wish your details to be used for this purpose, please contact Winnie Seah (database) on database@ibcasia.com.sg Tel: +65 6508 2468 or Fax: +65 6508 2408. Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event. Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407. Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC Asia will not be responsible for any event re-scheduled or cancelled. FREE GROUPDISCOUNT Please photocopy for additional delegates Delegate 1 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Who is Head of your Department? Who is Head of Training? Delegate 2 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 3 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 4 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Company Information Company Name: Address: Main Business/Activity: Postal Code: MEDICAL AFFAIRS FORUM ASIA 2012 ❑ I would like to purchase the conference presentations at SGD1000 + GST (SGD1070) per log in. RESERVE YOUR PLACE TODAY! CREDIT CARD PAYMENTS The best way to pay by credit card is through our secure on-line registration process, simply log on to the website at www.medicalaffairs- asia.com and click “Register On-line”. If you would prefer to pay over the phone please complete the contact name and details and our Customer Services Team will call within 24 hours to take payment. As we treat your credit card information in the strictest confidence, please do not send payment details by email. Credit card contact: Department: Direct phone number: Email: P46206 Payment Method (Please tick:) ❑ I enclose my bankers draft / cheque payable to IBC Asia (S) Pte Ltd ❑ I am paying by bank transfer (copy attached) ❑ Payment by Credit Card. (AMEX, VISA or MasterCard accepted) Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry date, registration and payment must be received by the cut-off date. • Payment by bankers draft or cheque in S$ or US$ should be made in favour of “IBC Asia (S) Pte Ltd” and mailed to: IBC Asia (S) Pte Ltd c/o Informa Regional Business Services 111 Somerset Road, TripleOne Somerset #10-06 Singapore 238164 Attn: The Accounts Receivable Team • Payment by bank transfer in S$ or US$ made payable to: IBC Asia (S) Pte Ltd A/C No.:147-059513-001 (S$) A/C No.:260-457866-178 (US$) The Hongkong and Shanghai Banking Corporation Limited 21 Collyer Quay, HSBC Building Singapore 049320 Bank Swift Code: HSBCSGSG Bank Code: 7232 • Payment by Credit Card (AMEX, VISA or MasterCard). The best way to pay by credit card is through our secure portal built into the website. To pay by phone please indicate the contact name and details below and our Customer Services Team will call within 24 hours to take payment. Please do not send credit card information by email. SAVE WITH THE EARLY BIRD & SPECIAL RATES! Register 3 delegates from the same company and the 4th delegate attends for FREE! ❑ 2 Day Conference only SGD 2,495 SGD 2,695 SGD 2,895 SGD 2,295 If undelivered, please return to: • Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time. Fee stated is the discounted price PER DELEGATE. Only one discount applies – either the early bird rate OR special rate or group rate. • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel. • A 7% Goods & Services Tax (GST) is applicable to all Singapore based companies for Singapore venue. 111 Somerset Road, TripleOne Somerset #10-06, Singapore 238164 Tel: +65 6508 2400 Fax: +65 6508 2408 SGD 2,895 SGD 3,095 SGD 3,295 SGD 2,695 GROUP BONUS – Register 3 Delegates from the same company and the 4th Delegate attends FREE! Grand Copthorne Waterfront Hotel 392 Havelock Road, Singapore 169663 Tel: +65 6233 1301 Fax: +65 6233 1177 Contact Person: Aili Tan Email: aili.tan@grandcopthorne.com.sg ❑ 2 Day Conference + Day Workshop2 1